Aurus Advisors
Aurus Advisors publicly describes investment-banking services spanning M&A, capital raises, restructurings, strategic partnerships, and advisory services. It also provides collateralized-financing services and identifies several technology and healthcare-related industry-focus areas.
What stands out about Aurus Advisors
Aurus Advisors is a FINRA-registered broker/dealer that publicly offers M&A, capital-raising, restructuring, strategic-partnership, advisory, and collateralized-financing services. Its cited investment-banking page does not publish a named archive of completed Aurus-advised transactions, transaction values, quantitative client-selection thresholds, or engagement-fee terms.[1][2][3][4][5][6][7]
What does Aurus Advisors do?
Aurus Advisors, Inc. operates under the Aurus Advisors name and identifies aurusadvisors.com as its official website. The firm publicly describes investment-banking services that include mergers and acquisitions, capital raises, restructurings, strategic partnerships, and advisory services. It also describes collateralized-financing services, including credit facilities, derivatives, repurchase agreements, letters of credit, and prime brokerage.[1][2][3]
Aurus’s investment-banking services cover mergers and acquisitions, capital raises, restructurings, strategic partnerships, and advisory services. Its collateralized-financing services include credit facilities, derivatives, repurchase agreements, letters of credit, and prime brokerage.[2][3]
Owners comparing advisory firms can also review Auxo’s M&A advisor vs. business broker vs. investment bank comparison, advisor-selection guide, and sell-side advisor evaluation framework.
What should a business owner evaluate before hiring Aurus Advisors?
Owners considering a sale or capital raise can evaluate Aurus against its publicly stated M&A, capital-raising, restructuring, strategic-partnership, advisory, and negotiation services, as well as its listed focus on Software/SaaS, AI, FinTech, HealthTech, Medical Devices, and Emerging Technology.
The cited investment-banking page does not provide a named archive of completed Aurus-advised transactions, transaction values, quantitative client-selection thresholds, or engagement-fee terms. Before engagement, an owner should request recent comparable mandates, permitted transaction tombstones, client references, Aurus’s role in each engagement, buyer or investor outreach evidence, valuation methodology, fee terms, conflicts disclosures, and expected process timing. The cited contact page also does not state a formal geographic mandate or limitation, so the scope of geographic coverage should be clarified.[2][4]
Which three or more recent M&A or capital-raising transactions did Aurus advise, on what dates, and what role did it perform
Can Aurus provide client references or permitted transaction tombstones
What transaction-size, revenue, EBITDA, growth, or profitability criteria apply
What size transactions and clients does Aurus Advisors focus on?
Aurus lists Software/SaaS, AI, FinTech, HealthTech, Medical Devices, and Emerging Technology as investment-banking industry-focus areas.[2]
Aurus’s About page states that Ascendant Behavioral Health, a mental-health treatment practice co-founded by Richard Augustus, was sold to LifeStance Health in January 2023. That page does not state that Aurus acted as financial advisor on the sale.
A 2010 SEC Form D identifies Aurus Advisors, Inc. as a sales-compensation recipient for an Alpha Titans LP offering with a first-sale date of December 1, 2007 and a reported total amount sold of $61,678,147 as of the August 9, 2010 filing. The Form D does not state that Aurus provided M&A advisory services for the offering.
Aurus’s official LinkedIn company page states that the firm has $10+ billion in closed transactions, but that page does not identify the transactions included in the aggregate figure.[5][6][7]
Aurus publicly identifies mergers and acquisitions, capital raises, restructurings, strategic partnerships, and advisory services as investment-banking activities. It states that it helps clients identify investors or acquirers and advises and assists in negotiating a transaction suited to the client’s company.[2]
What does Aurus Advisors publicly disclose about fees, process and engagement terms?
The cited investment-banking page does not publish a named archive of completed Aurus-advised transactions, transaction values, revenue, EBITDA, enterprise-value, transaction-size, employee-count, or other quantitative client-selection thresholds. That page also does not publish fee percentages, retainer amounts, minimum fees, tail periods, exclusivity terms, or termination provisions.
The cited About page does not state that Aurus acted as financial advisor on the January 2023 sale of Ascendant Behavioral Health to LifeStance Health. The cited SEC Form D does not state that Aurus provided M&A advisory services for the Alpha Titans LP offering. The cited official LinkedIn company page does not identify the transactions included in its aggregate $10+ billion closed-transactions figure.
The cited contact page provides office locations and contact information but does not state a formal geographic mandate or limitation for Aurus’s investment-banking engagements.[2][4][5][6][7]
Aurus’s official About page describes Aurus Advisors, Inc. as a FINRA-registered broker/dealer providing collateralized-finance and investment-banking services. The FINRA BrokerCheck firm report identifies AURUS ADVISORS, INC. as CRD #128096 and SEC #8-66089, with its main office in Ponte Vedra Beach, Florida. The report states that the firm is registered with the SEC, one self-regulatory organization, and three U.S. states or territories. A 2025 SEC-filed annual report identifies Aurus Advisors, Inc. as a broker-dealer for the reporting period January 1, 2025 through December 31, 2025.[5][8][9]
Aurus states that it helps clients identify investors or acquirers and advises and assists in negotiating a transaction suited to the client’s company. The cited investment-banking page does not publish a named archive of completed Aurus-advised transactions or transaction values.[2]
Questions to ask before hiring Aurus Advisors
Which three or more recent M&A or capital-raising transactions did Aurus advise, on what dates, and what role did it perform?
Can Aurus provide client references or permitted transaction tombstones?
What transaction-size, revenue, EBITDA, growth, or profitability criteria apply?
What are the engagement fee, success-fee, retainer, expense, exclusivity, tail, and termination provisions?
Which buyers or investors would be targeted, and how would Aurus assist with negotiation?
How are conflicts managed where Aurus also provides financing or works with banks, hedge funds, private-equity funds, or other capital providers?
Sources & research notes
- Official website / firm overview
- Services / capabilities
- Services / capabilities
- Geography / market coverage
- Transaction / portfolio evidence
- SEC filing / regulatory record
- Transaction / portfolio evidence
- FINRA regulatory record
- SEC filing / regulatory record
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.